AxoGen Inc (AXGN) Q3 2019 Earnings Call Transcript
AXGN earnings call for the period ending September 30, 2019.
AxoGen Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.
AXGN earnings call for the period ending September 30, 2019.
AXGN earnings call for the period ending June 30, 2019.
AXGN earnings call for the period ending March 31, 2019.
AXGN earnings call for the period ending December 31, 2018.
Investors wondering if they'll ever see a profit didn't get the outlook they wanted.
A scathing short-seller report started circulating at a bad time for the nerve repair specialist.
AXGN earnings call for the period ending September 30, 2018.
The healthcare company reported second-quarter 2018 earnings.
AXGN earnings call for the period ending December 31, 2017.
An $8,000 investment in these biotech stocks 10 years ago would be worth over $250,000 today. Are more gains ahead?